Stockscreener 앱 받기
250.43
0.75%
0.965
Abbvie Inc 주식(ABBV)의 최신 뉴스
Wells Fargo raises Abbvie stock price target on HS drug potential - Investing.com Canada
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026? - AOL.com
AbbVie Inc. $ABBV Shares Bought by Exchange Traded Concepts LLC - MarketBeat
Bellecapital International Ltd. Acquires 8,728 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Confluence Wealth Services Inc. - MarketBeat
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year - AOL.com
RWQ Financial Management Services Inc. Acquires 31,510 Shares of AbbVie Inc. $ABBV - MarketBeat
Mirae Asset Global Investments Co. Ltd. Has $124.56 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Campbell Newman Asset Management Inc. Sells 10,481 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Stock May Trade At A Premium Despite Cash Flow Upside - Yahoo Finance
SOA Wealth Advisors LLC. Sells 13,215 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stake Boosted by Envestnet Portfolio Solutions Inc. - MarketBeat
Kepler Cheuvreux (Suisse) SA's AbbVie Inc(ABBV) Holding History - GuruFocus
VIP Health Care Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
2 Reasons to Like ABBV and 1 to Stay Skeptical - Yahoo Finance
AbbVie Defends Its Turf, But Leaves One Big Question Open - Trefis
AbbVie Inc. SEC Filing (Aug 14, 2026) - Stock Titan
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026? - Yahoo Finance
AbbVie (NYSE:ABBV): Is More Momentum Ahead? - Kalkine Media
AbbVie Inc. (ABBV) Stock Forecasts - Yahoo Finance
Thomasville National Bank Buys Shares of 26,575 AbbVie Inc. $ABBV - MarketBeat
Clarity Financial LLC Has $50.02 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab? - Yahoo Finance
Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth? - Yahoo Finance
Wolfe Research Issues Rare Double Upgrade for Biogen and AbbVie, Setting $300 Targets - finance.biggo.com
Why Is AbbVie (NYSE:ABBV) In Focus as Immunology Franchise Draws Attention Worth Watching? - kalkinemedia.com
ABBV Upgraded by Wolfe Research -- Price Target Raised to $300 - GuruFocus
Could Why Is AbbVie (NYSE:ABBV) in View as the Broad Market Nears Records Stay in Focus? - Kalkine Media
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation - Yahoo Finance
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More - Yahoo Finance
Wolfe Upgrades AbbVie to Outperform From Peer Perform, Price Target is $300 - marketscreener.com
AbbVie Inc. $ABBV Shares Acquired by Mission Wealth Management LP - MarketBeat
Moody Lynn Lieberson & Walker LLC Has $42.52 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Harmony Asset Management LLC Boosts Holdings in AbbVie Inc. $ABBV - MarketBeat
Riverchase Wealth Management LLC Buys New Position in AbbVie Inc. $ABBV - MarketBeat
FOCUSED GLOBAL GROWTH FUND's AbbVie Inc(ABBV) Holding History - GuruFocus
How ABBV Stock Moved Away From Its Peer Group - Trefis
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield - 24/7 Wall St.
LVIP ClearBridge Franklin Select Large Cap Managed Volatility Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
Horizon Multi-Factor U.S. Equity Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
Prediction: AbbVie Will End The Year at This Price - AOL.com
AbbVie Inc. $ABBV Shares Bought by Wedge Capital Management L L P NC - MarketBeat
BTIG downgrades Apogee Therapeutics stock rating after AbbVie deal - Investing.com
Cardinal Capital Management Inc. Buys 21,206 Shares of AbbVie Inc. $ABBV - MarketBeat
How the Parkinson’s Disease Community and AbbVie Are Shaping the Future of Care - AbbVie
GODSEY & GIBB, INC's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie (ABBV) Wins Canada Reimbursement Backing For Adult Migraine Treatment - Yahoo Finance
AbbVie (ABBV) Gains On Botox Filing, Is The 9% Discount Still There? - Yahoo Finance
Why Is AbbVie (NYSE:ABBV) the Healthcare Name Riding Its Immunology Momentum? - Kalkine Media
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
ABBV Maintained by BNP Paribas -- Price Target Raised to $247 - GuruFocus
BNP Paribas Exane Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock - MarketBeat
Integrity Advisory Solutions, LLC's AbbVie Inc(ABBV) Holding History - GuruFocus
BNP Paribas Adjusts Price Target on AbbVie to $247 From $218, Maintains Neutral Rating - marketscreener.com
Allergan Aesthetics adds quarterly Botox rebate for qualifying growth - Stock Titan
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? - Yahoo Finance
AbbVie Inc. $ABBV Position Cut by Handelsbanken Fonder AB - MarketBeat
KMG Fiduciary Partners LLC Cuts Stake in AbbVie Inc. $ABBV - MarketBeat
Carolina Wealth Advisors LLC Purchases 7,626 Shares of AbbVie Inc. $ABBV - MarketBeat
Global drugmakers invest billions to boost US presence - Reuters
Osterweis Growth & Income Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie, Novartis Seek Block Illinois 340B Drug Discount Law - Law360
Pharma giants, including AbbVie, sue to block Illinois drug discount law - Crain's Chicago Business
AbbVie’s (ABBV) Botox Just Got A Step Closer To A Fifth Use - Yahoo Finance
AbbVie, Novartis Sue Illinois Over Hospital Drug Pharmacy Law - Bloomberg Law News
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings? - The Motley Fool
Apogee reports $85.9 million Q2 loss as AbbVie deal advances - quiverquant.com
0.12%
0.04%
자본화:
|
볼륨(24시간):